- Home
- Publications
- Publication Search
- Publication Details
Title
Survivin: a unique target for tumor therapy
Authors
Keywords
Survivin, Immunotherapy, Apoptosis, IAPs
Journal
Cancer Cell International
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-24
DOI
10.1186/s12935-016-0326-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Essential Role for Survivin in the Proliferative Expansion of Progenitor and Mature B Cells
- (2016) Ana V. Miletic et al. JOURNAL OF IMMUNOLOGY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- The Functional Repertoire of Survivin's Tails
- (2015) Sally P Wheatley CELL CYCLE
- Recent Advances on Small-Molecule Survivin Inhibitors
- (2015) Min Xiao et al. CURRENT MEDICINAL CHEMISTRY
- Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent manner
- (2015) Pawan Kumar et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties
- (2015) Min Xiao et al. PLoS One
- Cancer and the Immune System: Basic Concepts and Targets for Intervention
- (2015) Drew Pardoll SEMINARS IN ONCOLOGY
- Preclinical development of HIvax: Human survivin highly immunogenic vaccines
- (2015) Peter R Hoffmann et al. Human Vaccines & Immunotherapeutics
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall Survival
- (2015) Anna G. Antonacopoulou et al. Analytical Cellular Pathology
- siRNA-mediated Silencing of Survivin Inhibits Proliferation and Enhances Etoposide Chemosensitivity in Acute Myeloid Leukemia Cells
- (2014) Hadi Karami et al. Asian Pacific Journal of Cancer Prevention
- Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors
- (2014) Volker Lennerz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- KLF5 Regulates the Integrity and Oncogenicity of Intestinal Stem Cells
- (2014) T. Nakaya et al. CANCER RESEARCH
- Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
- (2014) Junya Ohtake et al. IMMUNOLOGY LETTERS
- Comprehensive Analysis of HLA-DR- and HLA-DP4-Restricted CD4+ T Cell Response Specific for the Tumor-Shared Antigen Survivin in Healthy Donors and Cancer Patients
- (2014) X.-F. Wang et al. JOURNAL OF IMMUNOLOGY
- Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1
- (2014) S Fukuda et al. LEUKEMIA
- Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription
- (2014) Jaime G Fernández et al. Molecular Cancer
- Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas
- (2014) T. Doucette et al. NEURO-ONCOLOGY
- Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency
- (2014) Amber N. Mull et al. Stem Cell Research
- Sox2 protects neural stem cells from apoptosis via up-regulating survivin expression
- (2013) Ruopeng Feng et al. BIOCHEMICAL JOURNAL
- Clinico-pathologic relevance of Survivin splice variant expression in cancer
- (2013) Rosalia de Necochea-Campion et al. CANCER LETTERS
- Survivin promotion of melanoma metastasis requires upregulation of α 5 integrin
- (2013) Jodi A. McKenzie et al. CARCINOGENESIS
- Tapping the treasure of intracellular oncotargets with immunotherapy
- (2013) Cheng William Hong et al. FEBS LETTERS
- Fowlpox-based survivin vaccination for malignant mesothelioma therapy
- (2013) Pietro Bertino et al. INTERNATIONAL JOURNAL OF CANCER
- CD4+ T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models
- (2013) Rajesh K. Sharma et al. PLoS One
- Survivin – biology and potential as a therapeutic target in oncology
- (2013) Jang-Yang Chang et al. OncoTargets and Therapy
- Human Vaccines & Immunotherapeutics
- (2013) Eva M. Riedmann Human Vaccines & Immunotherapeutics
- Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
- (2012) Jürgen C. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer
- (2012) Xiaopeng Cai et al. Diagnostic Pathology
- YM155 Induces EGFR Suppression in Pancreatic Cancer Cells
- (2012) Young-Soon Na et al. PLoS One
- A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity
- (2012) Xiang Ling et al. PLoS One
- SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ
- (2012) Shravan Madireddi et al. PLoS One
- Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8+ T and NK Cell Dependent Manner
- (2012) Abhishek K. Srivastava et al. PLoS One
- OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
- (2012) Chunguang Li et al. PLoS One
- Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer
- (2012) Salma Khan et al. PLoS One
- Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients
- (2011) Hidekazu Kameshima et al. CANCER SCIENCE
- Induction of HLA-DP4–Restricted Anti-Survivin Th1 and Th2 Responses Using an Artificial Antigen-Presenting Cell
- (2011) Makito Tanaka et al. CLINICAL CANCER RESEARCH
- Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: Critical roles of IFNγ
- (2011) Srabanti Rakshit et al. INTERNATIONAL JOURNAL OF CANCER
- Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients
- (2011) Melanie Widenmeyer et al. INTERNATIONAL JOURNAL OF CANCER
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer
- (2011) Xiao-Yuan Chu et al. JOURNAL OF SURGICAL ONCOLOGY
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
- (2011) Ronan J Kelly et al. Molecular Cancer
- Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo
- (2011) Peng Wang et al. MOLECULAR CARCINOGENESIS
- Survivin is released from cancer cells via exosomes
- (2010) Salma Khan et al. APOPTOSIS
- Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice
- (2010) Ke Guo et al. CANCER BIOLOGY & THERAPY
- A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells
- (2010) Rui Zhang et al. CANCER BIOLOGY & THERAPY
- GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells
- (2010) Xianping Shi et al. CANCER BIOLOGY & THERAPY
- IAP Regulation of Metastasis
- (2010) Swarna Mehrotra et al. CANCER CELL
- A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy
- (2010) Chun Hei Antonio Cheung et al. Cancer Cell International
- Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
- (2010) Hidenobu Ishizaki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
- (2010) Akihiro Miyazaki et al. CANCER SCIENCE
- Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
- (2010) D. C. Talbot et al. CLINICAL CANCER RESEARCH
- Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
- (2010) Redas Trepiakas et al. CYTOTHERAPY
- Survivin Is a Potential Mediator of Prostate Cancer Metastasis
- (2010) Min Zhang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Survivin Selectively Modulates Genes Deregulated in Human Leukemia Stem Cells
- (2010) Seiji Fukuda et al. Journal of Oncology
- Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential
- (2009) S Khan et al. BRITISH JOURNAL OF CANCER
- Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
- (2009) Ichiya Honma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
- (2009) Uta B. Hofmann et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells
- (2008) Jenilyn J. Virrey et al. AMERICAN JOURNAL OF PATHOLOGY
- Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP21
- (2008) John W. Blankenship et al. BIOCHEMICAL JOURNAL
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
- (2008) Tetsuhiro Tsuruma et al. Journal of Translational Medicine
- IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis
- (2008) Mads Gyrd-Hansen et al. NATURE CELL BIOLOGY
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now